120 related articles for article (PubMed ID: 2430738)
1. Affinity chromatographic separation of alpha-fetoprotein variants: development of a mini-column procedure, and application to cancer patients.
Chan DW; Miao YC
Clin Chem; 1986 Dec; 32(12):2143-6. PubMed ID: 2430738
[TBL] [Abstract][Full Text] [Related]
2. Affinity chromatography used in distinguishing alpha-fetoprotein in serum from patients with tumors of hepatic parenchyma and of germ cells.
Buamah PK; Cornell C; Skillen AW
Clin Chem; 1984 Jul; 30(7):1257-8. PubMed ID: 6203669
[TBL] [Abstract][Full Text] [Related]
3. Lectin-reactive profiles of alpha-fetoprotein characterizing hepatocellular carcinoma and related conditions.
Taketa K; Sekiya C; Namiki M; Akamatsu K; Ohta Y; Endo Y; Kosaka K
Gastroenterology; 1990 Aug; 99(2):508-18. PubMed ID: 1694805
[TBL] [Abstract][Full Text] [Related]
4. Serum alpha-fetoprotein levels and microheterogeneity in patients with different liver diseases.
Nikolić JA; Stajić M; Cuperlović M; Hajduković L; Golubović G
J Hepatol; 1990 Sep; 11(2):252-6. PubMed ID: 1701455
[TBL] [Abstract][Full Text] [Related]
5. Alpha-fetoprotein-lectin binding as a marker of tumour activity or liver damage.
Marrink J; Sleijfer DT; de Vries EG; Schraffordt Koops H
Eur J Cancer; 1990; 26(9):969-72. PubMed ID: 1703772
[TBL] [Abstract][Full Text] [Related]
6. Concanavalin A affinity of alpha-fetoprotein. Its use in differentiating tumors.
Govindarajan S; Fong TL; Ashcavai M
Am J Clin Pathol; 1987 Dec; 88(6):722-4. PubMed ID: 2446494
[TBL] [Abstract][Full Text] [Related]
7. Changes in serum alpha-fetoprotein and chorionic gonadotropin in response to cancer therapy.
Nisselbaum JS; Bosl GJ; Golbey RB; Schwartz DC; Schwartz MK
Ann Clin Lab Sci; 1984; 14(3):179-88. PubMed ID: 6203466
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a monoclonal immunoenzymometric assay for alpha-fetoprotein.
Chan DW; Kelsten M; Rock R; Bruzek D
Clin Chem; 1986 Jul; 32(7):1318-22. PubMed ID: 2424638
[TBL] [Abstract][Full Text] [Related]
9. Serum-alpha 1-fetoprotein in hepatocellular carcinoma.
Kohn J; Weaver PC
Lancet; 1974 Aug; 2(7876):334-6. PubMed ID: 4136060
[No Abstract] [Full Text] [Related]
10. Specific enzyme immunoassay for alpha-fetoprotein from hepatocellular carcinoma.
Kohno T; Kitamura T; Tsuda K; Ishikawa E
J Clin Lab Anal; 1990; 4(1):74-8. PubMed ID: 1690279
[TBL] [Abstract][Full Text] [Related]
11. Serial serum AFP heterogeneity changes in patients with hepatocellular carcinoma during chemotherapy.
Buamah PK; Cornell C; James OF; Skillen AW; Harris AL
Cancer Chemother Pharmacol; 1986; 17(2):182-4. PubMed ID: 2424626
[TBL] [Abstract][Full Text] [Related]
12. Alpha fetoprotein in hepatomas.
Kelkar SS; Talib VH; Khare PM; Menon GG
Indian J Med Res; 1975 May; 63(5):631-4. PubMed ID: 55382
[No Abstract] [Full Text] [Related]
13. The usefulness of simultaneous determinations of glucosaminylation and fucosylation indices of alpha-fetoprotein in the differential diagnosis of neoplastic diseases of the liver.
Aoyagi Y; Suzuki Y; Igarashi K; Saitoh A; Oguro M; Yokota T; Mori S; Nomoto M; Isemura M; Asakura H
Cancer; 1991 May; 67(9):2390-4. PubMed ID: 1707341
[TBL] [Abstract][Full Text] [Related]
14. Radioimmunoassay for human alpha 1 -fetoprotein.
Silver HK; Gold P; Feder S; Freedman SO; Shuster J
Proc Natl Acad Sci U S A; 1973 Feb; 70(2):526-30. PubMed ID: 4119791
[TBL] [Abstract][Full Text] [Related]
15. Molecular heterogeneity of human chorionic gonadotropin and its subunits in testicular cancer.
Mann K; Karl HJ
Cancer; 1983 Aug; 52(4):654-60. PubMed ID: 6305481
[TBL] [Abstract][Full Text] [Related]
16. Fucosylation of serum alpha-fetoprotein in patients with primary hepatocellular carcinoma.
Aoyagi Y; Isemura M; Yosizawa Z; Suzuki Y; Sekine C; Ono T; Ichida F
Biochim Biophys Acta; 1985 Aug; 830(3):217-23. PubMed ID: 2411292
[TBL] [Abstract][Full Text] [Related]
17. Plasma abnormal prothrombin (des-gamma-carboxy prothrombin) as a marker of hepatocellular carcinoma.
Fujiyama S; Morishita T; Hashiguchi O; Sato T
Cancer; 1988 Apr; 61(8):1621-8. PubMed ID: 2450634
[TBL] [Abstract][Full Text] [Related]
18. Serum alpha fetoprotein heterogeneity as a means of differentiating between primary hepatocellular carcinoma and hepatic secondaries.
Buamah PK; Gibb I; Bates G; Ward AM
Clin Chim Acta; 1984 Jun; 139(3):313-6. PubMed ID: 6204793
[TBL] [Abstract][Full Text] [Related]
19. Clinical evaluation of plasma abnormal prothrombin (PIVKA-II) in patients with hepatocellular carcinoma.
Fujiyama S; Morishita T; Sagara K; Sato T; Motohara K; Matsuda I
Hepatogastroenterology; 1986 Oct; 33(5):201-5. PubMed ID: 2433199
[TBL] [Abstract][Full Text] [Related]
20. Establishment of assay kits for the determination of microheterogeneities of alpha-fetoprotein using lectin-affinity electrophoresis.
Shimizu K; Taniichi T; Satomura S; Matsuura S; Taga H; Taketa K
Clin Chim Acta; 1993 Jan; 214(1):3-12. PubMed ID: 7680970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
